Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

(2010) Joseph N Jarvis et al.   BMC INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Voriconazole use and pharmacokinetics in combination with interferon-γ for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir

(2010) Natalie E. Nierenberg et al.   MEDICAL MYCOLOGY

Combination Efficacy of Voriconazole and Amphotericin B in the Experimental Disease in Immunodeficient Mice Caused by Fluconazole-resistant Cryptococcus neoformans

(2010) Eriques Gonçalves Silva et al.   MYCOPATHOLOGIA

The burden of HIV-associated cryptococcal disease

(2009) Thomas S Harrison   AIDS

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Long-Term Efficacy and Safety of TDM-Assisted Combination of Voriconazole plus Efavirenz in an AIDS Patient with Cryptococcosis and Liver Cirrhosis

(2009) Sergio Carbonara et al.   ANNALS OF PHARMACOTHERAPY

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

(2009) Roger J. M. Brüggemann et al.   CLINICAL INFECTIOUS DISEASES

A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV‐Associated Cryptococcal Meningitis

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients

(2009) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi

(2009) Jesse C. Nussbaum et al.   CLINICAL INFECTIOUS DISEASES

Complexity of Interactions Between Voriconazole and Antiretroviral Agents

(2008) Erin M Yakiwchuk et al.   ANNALS OF PHARMACOTHERAPY

Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy

(2008) Andrew Kambugu et al.   CLINICAL INFECTIOUS DISEASES

Dose Response Effect of High‐Dose Fluconazole for HIV‐Associated Cryptococcal Meningitis in Southwestern Uganda

(2008) Nicky Longley et al.   CLINICAL INFECTIOUS DISEASES

High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized Trial

(2008) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis

(2008) Eric Milefchik et al.   MEDICAL MYCOLOGY

Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects

(2007) Ping Liu et al.   JOURNAL OF CLINICAL PHARMACOLOGY